National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 288459

(NOTE: This result is from the 2/14/2018 version of the VAERS database)

Case Details

VAERS ID: 288459 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: West Virginia  
   Days after vaccination:0
Submitted: 2007-08-17
   Days after onset:46
Entered: 2007-08-20
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 - / IM

Administered by: Other       Purchased by: Other
Symptoms: Abortion induced, Drug exposure during pregnancy, Urine human chorionic gonadotropin positive
SMQs:, Tumour markers (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XANAX
Current Illness: Pregnancy NOS (LMP = 5/24/2007); Bipolar disorder; Headache
Preexisting Conditions:
Diagnostic Lab Data: urine beta-human 07/02/07 posit
CDC Split Type: WAES0707USA00550

Write-up: Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.

New Search

Link To This Search Result:

Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166